Clinical Trial Update: Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ganitumab with gemcitabine and radiation therapy, followed by ganitumab with capecitabine and maintenance therapy, in locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ganitumab (ganitumab)
• Gemzar (gemcitabine)
• Xeloda (capecitabine)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED